Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Protocol for in vitro co-culture, proliferation, and cell cycle analyses of patient-derived leukemia cells

Lookup NU author(s): Dr Sean HockneyORCiD, Carly Knill, Dr David McDonald, Professor Andrew FilbyORCiD, Dr Deepali Pal

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2024 The Authors. Leukemia niche impacts quiescence; however, culturing patient-derived samples ex vivo is technically challenging. Here, we present a protocol for in vitro co-culture of patient-derived xenograft acute lymphoblastic leukemia (PDX-ALL) cells with human mesenchymal stem cells (MSCs). We describe steps for labeling PDX-ALL cells with CellTrace Violet dye to demonstrate MSC-primed PDX-ALL cycling. We then detail procedures to identify MSC-primed G0/quiescent PDX-ALL cells via Hoechst-33342/Pyronin Y live cell cycle analysis. For complete details on the use and execution of this protocol, please refer to Pal et al.


Publication metadata

Author(s): Parker J, Hockney S, Knill C, McDonald D, Filby A, Pal D

Publication type: Article

Publication status: Published

Journal: STAR Protocols

Year: 2024

Volume: 5

Issue: 3

Print publication date: 20/09/2024

Online publication date: 20/07/2024

Acceptance date: 02/04/2018

Date deposited: 29/07/2024

ISSN (electronic): 2666-1667

Publisher: Cell Press

URL: https://doi.org/10.1016/j.xpro.2024.103202

DOI: 10.1016/j.xpro.2024.103202


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
CCLGA 2016 05 BH160568
Children’s Cancer and Leukaemia Group (CCLG)
NC/V001639/1
NC/P002412/1National Centre for the Replacement, Refinement and Reduction of Animals NC3R

Share